Medicine recalls
|
| |
| Singapore: Recall of Apo-Acyclovir Tablet 800mg |
| |
Health Sciences Authority (HSA) announces that Pharmaforte Singapore Pte Ltd is recalling one batch of Apo-Acyclovir Tablet 800mg (batch number: RP8516) at the retail level because an impurity, N-nitrosodimethylamine (NDMA), was found to be above the acceptable level.
Please refer to the following website in HSA for details:
http://www.hsa.gov.sg/announcements/product-recall/recall-of-apo-acyclovir-tablet-800mg-tablets
In Hong Kong, Apo-Acyclovir Tab 800mg (HK-58228) is a pharmaceutical product registered by Hind Wing Co Ltd (Hind Wing). The product is a prescription-only medicine.
On 28 Apr 2022, the Department of Health endorsed Hind Wing to recall a total of 4 batches of the following 2 products from the market as a precautionary measure due to the presence of an impurity, N-nitrosodimethylamine (NDMA), in the products:
- Apo-Acyclovir Tab 200mg (HK-43427) (batch number: RH9368, RH9370)
- Apo-Acyclovir Tab 800mg (HK-58228) (batch number: RP8516, RP8517)
A press statement was issued on the same date.
Ends/Friday, Apr 29, 2022
Issued at HKT 15:00
|
| |
|
